Literature DB >> 26632358

Germline Manipulation and Our Future Worlds.

John Harris1.   

Abstract

Two genetic technologies capable of making heritable changes to the human genome have revived interest in, and in some quarters a very familiar panic concerning, so-called germline interventions. These technologies are: most recently the use of CRISPR/Cas9 to edit genes in non-viable IVF zygotes and Mitochondrial Replacement Therapy (MRT) the use of which was approved in principle in a landmark vote earlier this year by the United Kingdom Parliament. The possibility of using either of these techniques in humans has encountered the most violent hostility and suspicion. However it is important to be aware that much of this hostility dates back to the fears associated with In Vitro Fertilization (IVF) and other reproductive technologies and by cloning; fears which were baseless at the time concerning both IVF and cloning the use of both of which have proved to be highly beneficial to humanity and which have been effectively regulated and controlled. This paper argues that CRISPR should by pursued through researh until it is safe enough for use in humans but there is no reason to suppose at this stage that such use will be unsafe or unethical (Collins 2015).

Entities:  

Keywords:  Germline modification, CRISPR/Cas9, Mitochondrial Transfer, Epigenetics

Mesh:

Year:  2015        PMID: 26632358     DOI: 10.1080/15265161.2015.1104163

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  9 in total

1.  Toward Anticipatory Governance of Human Genome Editing: A Critical Review of Scholarly Governance Discourse.

Authors:  John P Nelson; Cynthia L Selin; Christopher T Scott
Journal:  J Responsible Innov       Date:  2021-07-29

2.  Clinical application of whole-exome sequencing: A retrospective, single-center study.

Authors:  Qiang Zhang; Zailong Qin; Shang Yi; Hao Wei; Xun Zhao Zhou; Jiasun Su
Journal:  Exp Ther Med       Date:  2021-05-12       Impact factor: 2.447

3.  A CRISPR New World: Attitudes in the Public toward Innovations in Human Genetic Modification.

Authors:  Steven M Weisberg; Daniel Badgio; Anjan Chatterjee
Journal:  Front Public Health       Date:  2017-05-22

Review 4.  Emerging ethical perspectives in the clustered regularly interspaced short palindromic repeats genome-editing debate.

Authors:  Silvia Camporesi; Giulia Cavaliere
Journal:  Per Med       Date:  2016-10-28       Impact factor: 2.512

5.  Resource Allocation, Treatment, Disclosure, and Mitochondrial Replacement Techniques.

Authors:  César Palacios-González
Journal:  Camb Q Healthc Ethics       Date:  2017-04       Impact factor: 1.284

6.  Trust in Science: CRISPR-Cas9 and the Ban on Human Germline Editing.

Authors:  Stephan Guttinger
Journal:  Sci Eng Ethics       Date:  2017-06-26       Impact factor: 3.525

Review 7.  Human germline genome editing is illegal in Canada, but could it be desirable for some members of the rare disease community?

Authors:  Erika Kleiderman; Ian Norris Kellner Stedman
Journal:  J Community Genet       Date:  2019-08-16

8.  Germline gene editing and the precautionary principle.

Authors:  Julian J Koplin; Christopher Gyngell; Julian Savulescu
Journal:  Bioethics       Date:  2019-06-27       Impact factor: 1.898

Review 9.  Mitochondrial replacement techniques: egg donation, genealogy and eugenics.

Authors:  César Palacios-González
Journal:  Monash Bioeth Rev       Date:  2016-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.